List of Tables
Table 1. Global Anti-myopia Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Anti-myopia Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Anti-myopia Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Anti-myopia Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Anti-myopia Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Anti-myopia Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Anti-myopia Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Anti-myopia Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Anti-myopia Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Anti-myopia Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-myopia Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Anti-myopia Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-myopia Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-myopia Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-myopia Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Anti-myopia Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Anti-myopia Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Anti-myopia Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Anti-myopia Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Anti-myopia Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Anti-myopia Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Anti-myopia Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Anti-myopia Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Anti-myopia Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Anti-myopia Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Anti-myopia Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Anti-myopia Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Anti-myopia Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Anti-myopia Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Anti-myopia Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Anti-myopia Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Anti-myopia Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Anti-myopia Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Anti-myopia Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Anti-myopia Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Anti-myopia Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Anti-myopia Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Anti-myopia Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Anti-myopia Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Anti-myopia Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Anti-myopia Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Anti-myopia Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Anti-myopia Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Anti-myopia Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Anti-myopia Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Anti-myopia Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Anti-myopia Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Anti-myopia Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Anti-myopia Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Anti-myopia Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Anti-myopia Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Anti-myopia Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Anti-myopia Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Anti-myopia Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Anti-myopia Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Anti-myopia Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Anti-myopia Drugs Price (US$/Unit) by Type (2020-2025)
Table 59. Global Anti-myopia Drugs Price (US$/Unit) by Type (2026-2031)
Table 60. Global Anti-myopia Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Anti-myopia Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Anti-myopia Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Anti-myopia Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Anti-myopia Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Anti-myopia Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Anti-myopia Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Anti-myopia Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Anti-myopia Drugs Price (US$/Unit) by Application (2020-2025)
Table 69. Global Anti-myopia Drugs Price (US$/Unit) by Application (2026-2031)
Table 70. Dioptragen Therapeutics Company Information
Table 71. Dioptragen Therapeutics Description and Business Overview
Table 72. Dioptragen Therapeutics Anti-myopia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Dioptragen Therapeutics Anti-myopia Drugs Product
Table 74. Dioptragen Therapeutics Recent Developments/Updates
Table 75. Sydnexis Company Information
Table 76. Sydnexis Description and Business Overview
Table 77. Sydnexis Anti-myopia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Sydnexis Anti-myopia Drugs Product
Table 79. Sydnexis Recent Developments/Updates
Table 80. Vyluma Company Information
Table 81. Vyluma Description and Business Overview
Table 82. Vyluma Anti-myopia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Vyluma Anti-myopia Drugs Product
Table 84. Vyluma Recent Developments/Updates
Table 85. ALCON LABORATORIES, INC. Company Information
Table 86. ALCON LABORATORIES, INC. Description and Business Overview
Table 87. ALCON LABORATORIES, INC. Anti-myopia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. ALCON LABORATORIES, INC. Anti-myopia Drugs Product
Table 89. ALCON LABORATORIES, INC. Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Anti-myopia Drugs Distributors List
Table 93. Anti-myopia Drugs Customers List
Table 94. Anti-myopia Drugs Market Trends
Table 95. Anti-myopia Drugs Market Drivers
Table 96. Anti-myopia Drugs Market Challenges
Table 97. Anti-myopia Drugs Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Product Picture of Anti-myopia Drugs
Figure 2. Global Anti-myopia Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Anti-myopia Drugs Market Share by Type: 2024 & 2031
Figure 4. Atropine Product Picture
Figure 5. Tropicamide Eye Drops Product Picture
Figure 6. Compound Tropicamide Eye Drops Product Picture
Figure 7. Global Anti-myopia Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Anti-myopia Drugs Market Share by Application: 2024 & 2031
Figure 9. Online Pharmacy
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Global Anti-myopia Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Anti-myopia Drugs Market Size (2020-2031) & (US$ Million)
Figure 15. Global Anti-myopia Drugs Sales (2020-2031) & (K Units)
Figure 16. Global Anti-myopia Drugs Average Price (US$/Unit) & (2020-2031)
Figure 17. Anti-myopia Drugs Report Years Considered
Figure 18. Anti-myopia Drugs Sales Share by Manufacturers in 2024
Figure 19. Global Anti-myopia Drugs Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Anti-myopia Drugs Players: Market Share by Revenue in Anti-myopia Drugs in 2024
Figure 21. Anti-myopia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Anti-myopia Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Anti-myopia Drugs Sales Market Share by Country (2020-2031)
Figure 24. North America Anti-myopia Drugs Revenue Market Share by Country (2020-2031)
Figure 25. United States Anti-myopia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Anti-myopia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Anti-myopia Drugs Sales Market Share by Country (2020-2031)
Figure 28. Europe Anti-myopia Drugs Revenue Market Share by Country (2020-2031)
Figure 29. Germany Anti-myopia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Anti-myopia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Anti-myopia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Anti-myopia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Anti-myopia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Anti-myopia Drugs Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Anti-myopia Drugs Revenue Market Share by Region (2020-2031)
Figure 36. China Anti-myopia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Anti-myopia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Anti-myopia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Anti-myopia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Anti-myopia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Anti-myopia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Anti-myopia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Anti-myopia Drugs Sales Market Share by Country (2020-2031)
Figure 44. Latin America Anti-myopia Drugs Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Anti-myopia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Anti-myopia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Anti-myopia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Anti-myopia Drugs Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Anti-myopia Drugs Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Anti-myopia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Anti-myopia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Anti-myopia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Anti-myopia Drugs by Type (2020-2031)
Figure 54. Global Revenue Market Share of Anti-myopia Drugs by Type (2020-2031)
Figure 55. Global Anti-myopia Drugs Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Anti-myopia Drugs by Application (2020-2031)
Figure 57. Global Revenue Market Share of Anti-myopia Drugs by Application (2020-2031)
Figure 58. Global Anti-myopia Drugs Price (US$/Unit) by Application (2020-2031)
Figure 59. Anti-myopia Drugs Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
